T-cell Lymphoma Clinical Trials

80 clinical trials for T-cell Lymphoma across international registries, including 20 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL) — RECRUITING · PHASE2
• Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL) — RECRUITING
• A Study of Enasidenib in People With T-Cell Lymphoma — RECRUITING · PHASE2
• CD4CAR for CD4+ Leukemia and Lymphoma — RECRUITING · PHASE1
• Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma — RECRUITING · PHASE2
• Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution — RECRUITING
• A Registry for People With T-cell Lymphoma — RECRUITING
• Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/NHL — RECRUITING · PHASE1
• Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma — RECRUITING · PHASE2
• Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma — RECRUITING · PHASE2
• BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20) — RECRUITING · PHASE1
• Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma — RECRUITING · PHASE1
• Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells — RECRUITING · PHASE2
• Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCL — RECRUITING · PHASE2
• Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing — RECRUITING
• CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas — RECRUITING · PHASE1
• CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas — RECRUITING · PHASE1
• Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells — RECRUITING · PHASE1
• Azacitidine-CHOP for Patients With Nodal T-cell Lymphoma With T-follicular Helper Phenotype (ACANTUS) — RECRUITING · PHASE1
• REal World Data in LYmphoma and Survival in Adults — RECRUITING
• Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma — SUSPENDED · PHASE1
• A Multi-center, Prospective, Registry Study to Analyze the Clinical Characteristics and Prognosis of Different Molecular Subtypes of Peripheral T-cell Lymphoma. — NOT_YET_RECRUITING
• Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas — TERMINATED · PHASE2
• Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica. — NOT_YET_RECRUITING
• Study of Tazemetostat in Lymphoid Malignancies — TERMINATED · PHASE1
• A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies — COMPLETED · PHASE1
• A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies — COMPLETED · PHASE1
• A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL) — COMPLETED · PHASE2
• A Study of Brentuximab Vedotin Treatment in Chinese Adults With CD30-Positive Cutaneous T-Cell Lymphoma — COMPLETED · PHASE4
• CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation — NOT_YET_RECRUITING · PHASE1
• A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell Lymphoma — ACTIVE_NOT_RECRUITING · PHASE1
• Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) — COMPLETED · PHASE1
• Understanding the Role of Large Extracellular Vesicles in Lymphomas and Lymphoproliferative Disorders: the "Off the Beaten Track" Liquid Biopsy — COMPLETED
• A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies (COBALT-LYM) — TERMINATED · PHASE1
• A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab Vedotin — COMPLETED
• Phase I Clinical Trial of Autologous CD7-CAR T Cell Therapy for High-risk Acute T-cell Leukemia/lymphoma — COMPLETED · PHASE1
• CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma — TERMINATED · PHASE2
• Tucidinostat, Azacitidine Combined With CHOP Versus CHOP in Patients With Untreated Peripheral T-cell Lymphoma — OTHER · PHASE3
• HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma — COMPLETED · PHASE2
• Treatment of Relapsed or Refractory Epstein-Barr Virus Positive T-cell Lymphoma With hNeo-T — OTHER · PHASE1
• Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation — COMPLETED · PHASE2
• Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma — OTHER · PHASE1
• A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma — OTHER
• Study of Ibrutinib in Relapsed and Refractory T-cell Lymphoma — COMPLETED · PHASE1
• Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer — COMPLETED
• Chidamide Combined With Azacitidine and Mitoxantrone Liposome in the Treatment of Relapsed/Refractory (nTFHL) — OTHER · NA
• Study of Brentuximab Vedotin as Therapy After Autologous Stem Cell Transplant in Cluster of Differentiation Antigen 30 (CD30) Positive Peripheral TCell Lymphomas — WITHDRAWN · PHASE2
• Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma — COMPLETED · PHASE1
• Efficacy and Safety of Chidamide Combined With BEAM Pretreatment Regimen in Autologous Transplantation for T-cell Lymphoma — OTHER · PHASE2
• LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T Lymphocyte Tumor — TERMINATED · PHASE1

Refine this search